1. Home
  2. LIDR vs FATE Comparison

LIDR vs FATE Comparison

Compare LIDR & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AEye Inc.

LIDR

AEye Inc.

HOLD

Current Price

$1.85

Market Cap

118.0M

ML Signal

HOLD

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

HOLD

Current Price

$1.21

Market Cap

124.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIDR
FATE
Founded
2013
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
118.0M
124.6M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
LIDR
FATE
Price
$1.85
$1.21
Analyst Decision
Strong Buy
Buy
Analyst Count
1
7
Target Price
$6.00
$3.92
AVG Volume (30 Days)
978.4K
1.8M
Earning Date
02-19-2026
03-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$182,000.00
$7,137,000.00
Revenue This Year
$9.07
N/A
Revenue Next Year
$2,660.98
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.49
$0.66
52 Week High
$6.44
$1.94

Technical Indicators

Market Signals
Indicator
LIDR
FATE
Relative Strength Index (RSI) 36.27 55.86
Support Level $1.91 $1.17
Resistance Level $2.15 $1.32
Average True Range (ATR) 0.10 0.09
MACD -0.01 0.02
Stochastic Oscillator 0.12 61.67

Price Performance

Historical Comparison
LIDR
FATE

About LIDR AEye Inc.

AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: